SCIASCIA THOMAS (CIK 1229946) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-26). Recent activity: Buy TRVI (2,631 shares), Sell TRVI (2,631 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-26 | Trevi Therapeutics, Inc. (TRVI) | Chief Scientific Officer | Buy | 2,631 | $3,762 |
| 2025-03-26 | Trevi Therapeutics, Inc. (TRVI) | Chief Scientific Officer | Sell | 2,631 | $17,365 |
Source: SEC Form 4 filings · as of 2025-03-26